Amy Clark

Senior Research Associate at Evidera

Amy Clark is an experienced professional in the fields of research and education, currently serving as a Senior Research Associate at Evidera since March 2021, focusing on Patient Centered Research and Clinical Outcome Assessment. Previously, Amy held the position of Research Associate II at Clinical Outcomes Solutions and worked as a lecturer and university instructor at Canterbury Christ Church University, contributing to the School of Human and Life Sciences. Amy's foundational experience includes roles as a Research Assistant at the Centre for Sport, Physical Education & Activity Research and as a Personal Trainer at The Weights Room, where responsibilities included fitness instruction for various age groups. Amy holds a PhD in Sport and Exercise Science (Sociology) and a BSc (Hons) in Sport and Exercise Science, both from Canterbury Christ Church University.

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Evidera

1 followers

Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.